Could cause temporary or reversible harm; serious harm is unlikely.
CGMP Deviations- AZIDO Impurity levels observed to be above acceptable limits .
| Brand name | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
| Generic name | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE |
| Active ingredient(s) | HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM |
| Distributed by / for | Direct Rx Dawsonville, GA 30534 Mfg. For Macleods Pharma USA, Inc. Plainsboro, NJ 08540 |
| NDC | 72189-290-90 |
| Full product label | Losartan Pot/HCTZ 100/12.5 mg 90 Tabs NDC 72189-290-90 Packaged and Distributed By: Direct Rx Dawsonville, GA 30534 Mfg. For Macleods Pharma USA, Inc. Plainsboro, NJ 08540 |
| Recalling firm | Direct Rx |
| Distribution | FL |
| Quantity | 11 bottles |
| Recall initiated | 2022-05-11 |
| Report date | 2022-06-01 |
| Recall completed | 2022-12-02 |
| Recall number | D-0893-2022 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Dawsonville GA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗